Edition:
United Kingdom

ARMO Biosciences Inc (ARMO.OQ)

ARMO.OQ on NASDAQ Stock Exchange Global Select Market

50.57USD
6:49pm GMT
Change (% chg)

$-0.21 (-0.41%)
Prev Close
$50.78
Open
$51.18
Day's High
$51.75
Day's Low
$50.36
Volume
25,366
Avg. Vol
--
52-wk High
$57.00
52-wk Low
$27.00

Chart for

About

ARMO Biosciences, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company focuses on developing immunotherapies for the treatment of cancer, cardiovascular disease, fibrosis and inflammation. The Company's platform molecule AM0010 is a pegylated form of recombinant human IL-10, which has immune... (more)

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-ARMO Biosciences Sees IPO Of Up To 6.7 Mln Shares Of Common Stock, Estimated IPO Price Between $14 And $16/Shr

* ARMO BIOSCIENCES INC SEES IPO OF UP TO 6.7 MILLION SHARES OF COMMON STOCK AND ESTIMATED IPO PRICE BETWEEN $14.00 AND $16.00 PER SHARE - SEC FILING

16 Jan 2018

Earnings vs. Estimates